...
首页> 外文期刊>Annals of epidemiology >Estimates of adults with indications for HIV pre-exposure prophylaxis?by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015
【24h】

Estimates of adults with indications for HIV pre-exposure prophylaxis?by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015

机译:鉴定艾滋病毒预曝光预防症的成人估计?通过管辖权,传输风险集团和种族/民族,美国,2015年

获取原文
获取原文并翻译 | 示例
           

摘要

PurposeEffectively measuring progress in delivering HIV pre-exposure prophylaxis (PrEP) requires subnational estimates of the number of adults with indications for its use that account for differences in HIV infection rates by transmission risk (risk) group and race/ethnicity. MethodsWe applied a multiplier method with 2015 Centers for Disease Control and Prevention surveillance data on proportions of HIV diagnoses by race/ethnicity and risk group and population-based estimates of risk group sizes to derive estimated numbers of adults with indications by risk group (men who have sex with men [MSM], heterosexually active adults [HET], and persons who inject drugs [PWID]) by race/ethnicity in each jurisdiction. ResultsAn estimated 1.1 million adults had indications for PrEP use in 2015: 813,970 MSM, 258,080 HET, and 72,510 persons who inject drugs, and 500,340 blacks, 282,260 Latinos, and 303,230 whites. Among HET, 176,670 females and 81,410 males had indications. The proportions of adults with indications in each risk and race/ethnicity group varied by jurisdiction. ConclusionsBlacks comprised the highest number of adults with indications showing that increasing PrEP use in this population must be the highest priority. MSM remain a priority because of the high number with indications. These estimates can be used as denominators to assess PrEP coverage and impact on HIV incidence at subnational levels.
机译:在提供艾滋病毒预曝光预防(PREP)的目的中的预缺测程度需要对其具有迹象表明,其使用传播风险(风险)集团和种族/种族的艾滋病毒感染率差异的患者的成年人的次数。方法网络应用了乘法器方法,2015年疾病控制和预防监测数据,按比例/种族和风险集团的比例诊断的艾滋病病毒诊断以及基于人口的风险组估计,通过风险群体推导出估计的成年人数量(男子与男性[MSM],异性肾上腺症活跃的成年人[HET]以及每条司法管辖区内的种族/种族注入药物[PWID]的人。结果估计有110万人有2015年预备使用的迹象:813,970 MSM,258,080个HET和72,510人注射药物,500,340黑色,282,260拉丁美洲和303,230个白人。在HET中,176,670名女性和81,410名男性有适应症。每个风险和种族/种族群体中具有适应症的成年人的比例因司法管辖区而变化。结论Blacks包括具有适应症的最多成年人,表明该人群中的准备使用增加必须是最优先级的。由于具有迹象的数量高,MSM仍然是优先级。这些估计可用作分母,以评估准备覆盖率和对艾滋病毒疫情发病率的影响。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号